Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Outcome of Board Meeting of the Company held ....
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Bayer CropScience approved unaudited financial results for the quarter ended June 30, 2025. Revenue from operations rose to ₹19,146 Mn from ₹16,314 Mn in the same quarter last year, a growth of about 17%. Profit for the period stood at ₹2,787 Mn versus ₹2,542 Mn a year ago, up roughly 10%. Earnings per share came in at ₹62.01 (not annualised) compared to ₹56.56 earlier. Total income increased to ₹19,333 Mn, while total expenses rose to ₹15,981 Mn from ₹13,429 Mn. Deloitte Haskins & Sells LLP issued a clean limited review report with no qualifications.
A steady quarter with double-digit revenue and profit growth, supported by the company's seasonal agri-care business. The clean auditor review and no flagged risks suggest business is on a stable track, though full-year performance depends on the upcoming cropping season.